The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain
- PMID: 2204816
- PMCID: PMC361256
- DOI: 10.1128/mcb.10.10.5473-5485.1990
The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain
Abstract
We have shown that the murine c-rel protein can act as a transcriptional transactivator in both yeast and mammalian cells. Fusion proteins generated by linking rel sequences to the DNA-binding domain of the yeast transcriptional activator GAL4 activate transcription from a reporter gene linked in cis to a GAL4 binding site. The full-length mouse c-rel protein (588 amino acids long) is a poor transactivator; however, the C-terminal portion of the protein between amino acid residues 403 to 568 is a potent transcriptional transactivator. Deletion of the N-terminal half of the c-rel protein augments its transactivation function. We propose that c-rel protein has an N-terminal regulatory domain and a C-terminal transactivation domain which together modulate its function as a transcriptional transactivator.
Similar articles
-
Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb.Cell. 1989 Jul 14;58(1):85-93. doi: 10.1016/0092-8674(89)90405-4. Cell. 1989. PMID: 2665942
-
Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.Oncogene. 2000 Feb 3;19(5):599-607. doi: 10.1038/sj.onc.1203376. Oncogene. 2000. PMID: 10698504
-
c-rel activates but v-rel suppresses transcription from kappa B sites.Proc Natl Acad Sci U S A. 1991 May 1;88(9):3715-9. doi: 10.1073/pnas.88.9.3715. Proc Natl Acad Sci U S A. 1991. PMID: 2023921 Free PMC article.
-
The inhibitory ankyrin and activator Rel proteins.Curr Opin Genet Dev. 1992 Apr;2(2):211-20. doi: 10.1016/s0959-437x(05)80276-x. Curr Opin Genet Dev. 1992. PMID: 1386268 Review.
-
NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.Int Rev Cytol. 1993;143:1-62. doi: 10.1016/s0074-7696(08)61873-2. Int Rev Cytol. 1993. PMID: 8449662 Review. No abstract available.
Cited by
-
Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor.EMBO J. 1991 Apr;10(4):927-32. doi: 10.1002/j.1460-2075.1991.tb08026.x. EMBO J. 1991. PMID: 1901265 Free PMC article.
-
In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.Biochem J. 2006 Nov 15;400(1):115-25. doi: 10.1042/BJ20060786. Biochem J. 2006. PMID: 16792530 Free PMC article.
-
The conserved redox-sensitive cysteine residue of the DNA-binding region in the c-Rel protein is involved in the regulation of the phosphorylation of the protein.Biochem J. 2000 Dec 1;352 Pt 2(Pt 2):583-91. Biochem J. 2000. PMID: 11085954 Free PMC article.
-
Acquisition of NFKB1-selective DNA binding by substitution of four amino acid residues from NFKB1 into RelA.Mol Cell Biol. 1993 Jul;13(7):3850-9. doi: 10.1128/mcb.13.7.3850-3859.1993. Mol Cell Biol. 1993. PMID: 8321192 Free PMC article.
-
The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1023-7. doi: 10.1073/pnas.90.3.1023. Proc Natl Acad Sci U S A. 1993. PMID: 8430069 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases